Virtu KCG Holdings’s Trinity Biotech TRIB Stock Holding History

Virtu KCG Holdings’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$81K	Buy	+90	New	+$76.5K	﹤0.01%	2473
2017 Q1	–	Sell	-79	Closed	-$82K	–	3739
2016 Q4	$82K	Buy	+79	New	+$81.6K	﹤0.01%	2979
2015 Q4	–	Sell	-85	Closed	-$146K	–	3937
2015 Q3	$146K	Buy	+85	New	+$205K	﹤0.01%	2712
2014 Q3	–	Sell	-59	Closed	-$205K	–	4060
2014 Q2	$205K	Sell	59 -14	-19%	-$49.8K	﹤0.01%	3047
2014 Q1	$264K	Buy	+73	New	+$287K	﹤0.01%	2662

Other funds holding TRIB

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Virtu KCG Holdings's TRIB Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Trinity Biotech (TRIB) in Q2 2017: 90 shares worth $81K. The stake represents ﹤0.01% of the portfolio and ranks #2473 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in TRIB as recently as Q4 2016.

Virtu KCG Holdings first reported a position in TRIB in Q1 2014 and has held it in 5 quarters since. The position peaked at $264K in Q1 2014. 56 funds tracked by Wall St. Rank hold TRIB as of Q2 2017.

Virtu KCG Holdings held 90 shares of Trinity Biotech worth $81K as of Q2 2017.
Trinity Biotech was a new Virtu KCG Holdings position in Q2 2017.
Trinity Biotech made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2473 holding.
Virtu KCG Holdings first reported a position in Trinity Biotech in Q1 2014 and has held it in 5 quarters since.
Virtu KCG Holdings's Trinity Biotech position peaked at $264K in Q1 2014.
56 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.